Mefford IN - Search Results

1

Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder.

Castellanos FX, Elia J, Kruesi MJ, Gulotta CS, Mefford IN, Potter WZ, Ritchie GF, Rapoport JL. Castellanos FX, et al. Among authors: mefford in. Psychiatry Res. 1994 Jun;52(3):305-16. doi: 10.1016/0165-1781(94)90076-0. Psychiatry Res. 1994. PMID: 7527565 Clinical Trial.

2

Stimulant drug treatment of hyperactivity: biochemical correlates.

Elia J, Borcherding BG, Potter WZ, Mefford IN, Rapoport JL, Keysor CS. Elia J, et al. Among authors: mefford in. Clin Pharmacol Ther. 1990 Jul;48(1):57-66. doi: 10.1038/clpt.1990.118. Clin Pharmacol Ther. 1990. PMID: 2196146 Clinical Trial.

3

A neuroanatomical and biochemical basis for attention deficit disorder with hyperactivity in children: a defect in tonic adrenaline mediated inhibition of locus coeruleus stimulation.

Mefford IN, Potter WZ. Mefford IN, et al. Med Hypotheses. 1989 May;29(1):33-42. doi: 10.1016/0306-9877(89)90164-3. Med Hypotheses. 1989. PMID: 2546021

4

Lithium effects on noradrenergic-linked adenylate cyclase activity in intact rat brain: an in vivo microdialysis study.

Masana MI, Bitran JA, Hsiao JK, Mefford IN, Potter WZ. Masana MI, et al. Among authors: mefford in. Brain Res. 1991 Jan 11;538(2):333-6. doi: 10.1016/0006-8993(91)90450-a. Brain Res. 1991. PMID: 1849439

5

Interacting neurotransmitter systems. A non-experimental approach to the 5HIAA-HVA correlation in human CSF.

Agren H, Mefford IN, Rudorfer MV, Linnoila M, Potter WZ. Agren H, et al. Among authors: mefford in. J Psychiatr Res. 1986;20(3):175-93. doi: 10.1016/0022-3956(86)90002-6. J Psychiatr Res. 1986. PMID: 2430098

6

Plasma catecholamines and their metabolites in obsessive-compulsive disorder.

Benkelfat C, Mefford IN, Masters CF, Nordahl TE, King AC, Cohen RM, Murphy DL. Benkelfat C, et al. Among authors: mefford in. Psychiatry Res. 1991 Jun;37(3):321-31. doi: 10.1016/0165-1781(91)90067-y. Psychiatry Res. 1991. PMID: 1891512

7

Early-onset alcoholics have lower cerebrospinal fluid 5-hydroxyindoleacetic acid levels than late-onset alcoholics.

Fils-Aime ML, Eckardt MJ, George DT, Brown GL, Mefford I, Linnoila M. Fils-Aime ML, et al. Arch Gen Psychiatry. 1996 Mar;53(3):211-6. doi: 10.1001/archpsyc.1996.01830030029006. Arch Gen Psychiatry. 1996. PMID: 8611057

8

A cerebrospinal fluid study of the pathophysiology of panic disorder associated with alcoholism.

George DT, Adinoff B, Ravitz B, Nutt DJ, De Jong J, Berrettini W, Mefford IN, Costa E, Linnoila M. George DT, et al. Among authors: mefford in. Acta Psychiatr Scand. 1990 Jul;82(1):1-7. doi: 10.1111/j.1600-0447.1990.tb01345.x. Acta Psychiatr Scand. 1990. PMID: 1698009

9

Hypothalamic-pituitary-adrenocortical activity in panic disorder: relationship to plasma catecholamine metabolites.

Gurguis GN, Mefford IN, Uhde TW. Gurguis GN, et al. Among authors: mefford in. Biol Psychiatry. 1991 Sep 1;30(5):502-6. doi: 10.1016/0006-3223(91)90312-a. Biol Psychiatry. 1991. PMID: 1657223 No abstract available.

10

Effects of xylazine on cerebrospinal fluid catecholamines in the rhesus monkey.

Mefford IN, Garrick NA. Mefford IN, et al. Brain Res. 1989 Jul 17;492(1-2):377-80. doi: 10.1016/0006-8993(89)90923-2. Brain Res. 1989. PMID: 2568878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters